USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/27033
Full metadata record
DC FieldValueLanguage
dc.contributor.authorIacubițchii, Maria-
dc.contributor.authorMoscalciuc, Alina-
dc.contributor.authorPaduca, Ala-
dc.contributor.authorBendelic, Eugeniu-
dc.date.accessioned2024-04-22T07:21:56Z-
dc.date.available2024-04-22T07:21:56Z-
dc.date.issued2024-
dc.identifier.citationIACUBIȚCHII, Maria, MOSCALCIUC, Alina, PADUCA, Ala, BENDELIC, Eugeniu. Amniotic membrane in ophthalmology. In: Cells and Tissues Transplantation. Actualities and Perspectives: the materials of the nat. scientific conf. with internat. particip., the 2nd ed. Chisinau, March 29-30th 2024: [abstracts]. Chişinău: CEP Medicina, 2024, p. 24. ISBN 978-9975-82-366-1.en_US
dc.identifier.isbn978-9975-82-366-1-
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/27033-
dc.description.abstractBackground. Amniotic membrane (AM) represents a thin membrane on the inner part of the placenta (A. C. Mamede, 2012) that can be used in ophthalmology, dentistry, urology, burn units, otorhinolaryngology, gynecology, and researches in stem cell technology (U. Sridhar, 2023). Growth factors and cytokines with anti-inflammatory, anti-bacterial, anti-immunogenic, anti-fibrotic, and promotion of epithelization qualities are delivered by the cells of AM (H. Elkhenany, 2022). The study aims to give a brief overview of the clinical uses of AM in ophthalmology. Methods and materials: Literature research was performed using the keywords “amniotic membrane transplant”, “amnion AND cornea”, “amnion AND ophthalmology”, “amnion AND ocular surface” and “amnion AND retina”. There were selected articles written in English, until 01/03/2020. Results. Due to its characteristics as nonimmunogenic, easily available, cosmetically acceptability, and good substrate for epithelial growth- the AM is used as a graft for epithelial cell growth, tectonic support for small perforations and thinning of cornea and sclera, and reconstruction for the ocular surface. Also, in vitreoretinal surgery, the applications of the AM have been extended, such as complicated retinal detachment, macular holes that failed to close, and end-stage age-related macular degeneration. All of these uses are now under investigation and its capacity to be assimilated into the retinal tissue without causing immunologic reactions or significant postoperative problems makes it a valuable basal membrane and a new strategy for treating various retinal diseases. Conclusion. Nowadays, the amniotic membrane is widely used for the ocular surface with great postoperative results. For the vitreoretinal use, it is needed further prospective, randomized controlled studies to confirm the obtained results.en_US
dc.language.isoenen_US
dc.publisherCEP Medicinaen_US
dc.relation.ispartofCells and tissues transplantation. Actualities and perspectives. The 2-nd edition. Chisinau, March 29-30th 2024en_US
dc.subjectamniotic membraneen_US
dc.subjectcorneaen_US
dc.subjectocular surfaceen_US
dc.subjectretinaen_US
dc.subjectvitreoretinal surgeryen_US
dc.titleAmniotic membrane in ophthalmologyen_US
dc.typeOtheren_US
Appears in Collections:The Materials of the National Scientific Conference with International Participation, the 2nd edition, Chisinau, March 29-30th 2024: [Abstracts]

Files in This Item:
File Description SizeFormat 
AMNIOTIC_MEMBRANE_IN_OPHTHALMOLOGY.pdf295.23 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback